Pyridoxal 5-phosphate therapy in a patient with myelodysplastic syndrome and adult onset congenital erythropoietic porphyria.
Yamauchi
K
K
Department of Internal Medicine, Tokai University School of Medicine, Japan.
Kushibiki
Y
Y
D000753:Anemia, Refractory / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D011164:Porphyrias / Q000150:complications / Q000151:congenital* / Q000652:urine; D011732:Pyridoxal Phosphate / Q000627:therapeutic use*; D014578:Uroporphyrins / Q000652:urine
D014578:Uroporphyrins; D011732:Pyridoxal Phosphate